FERRONI, PATRIZIA
 Distribuzione geografica
Continente #
NA - Nord America 8.649
AS - Asia 4.984
EU - Europa 1.259
SA - Sud America 473
Continente sconosciuto - Info sul continente non disponibili 459
AF - Africa 95
OC - Oceania 11
Totale 15.930
Nazione #
US - Stati Uniti d'America 7.811
TR - Turchia 1.782
SG - Singapore 1.293
CN - Cina 1.177
CA - Canada 754
IT - Italia 720
BR - Brasile 345
VN - Vietnam 280
EU - Europa 132
FR - Francia 104
IN - India 102
HK - Hong Kong 79
DE - Germania 68
GB - Regno Unito 63
RU - Federazione Russa 53
IE - Irlanda 52
BD - Bangladesh 49
AR - Argentina 45
MX - Messico 40
ID - Indonesia 34
ES - Italia 32
PK - Pakistan 30
FI - Finlandia 29
ZA - Sudafrica 28
IL - Israele 26
PL - Polonia 24
UA - Ucraina 22
IQ - Iraq 21
SC - Seychelles 19
JP - Giappone 18
NL - Olanda 18
CO - Colombia 16
EC - Ecuador 16
CL - Cile 15
SE - Svezia 15
CR - Costa Rica 14
PH - Filippine 13
SA - Arabia Saudita 13
VE - Venezuela 13
MA - Marocco 12
LT - Lituania 10
KE - Kenya 9
PY - Paraguay 9
AU - Australia 8
AE - Emirati Arabi Uniti 7
IR - Iran 7
KR - Corea 7
MY - Malesia 7
DK - Danimarca 6
TN - Tunisia 6
UY - Uruguay 6
UZ - Uzbekistan 6
CZ - Repubblica Ceca 5
EG - Egitto 5
GT - Guatemala 5
JM - Giamaica 5
RO - Romania 5
BG - Bulgaria 4
BO - Bolivia 4
ET - Etiopia 4
HN - Honduras 4
JO - Giordania 4
LB - Libano 4
PE - Perù 4
TH - Thailandia 4
AL - Albania 3
BA - Bosnia-Erzegovina 3
KZ - Kazakistan 3
NP - Nepal 3
PA - Panama 3
PT - Portogallo 3
SN - Senegal 3
SV - El Salvador 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AO - Angola 2
AT - Austria 2
AZ - Azerbaigian 2
BB - Barbados 2
BS - Bahamas 2
BY - Bielorussia 2
CH - Svizzera 2
DO - Repubblica Dominicana 2
GR - Grecia 2
KH - Cambogia 2
LV - Lettonia 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
OM - Oman 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
XK - ???statistics.table.value.countryCode.XK??? 2
AD - Andorra 1
AM - Armenia 1
BE - Belgio 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BW - Botswana 1
CD - Congo 1
DZ - Algeria 1
GD - Grenada 1
Totale 15.591
Città #
Kocaeli 1.570
San Mateo 1.183
Dallas 900
San Jose 835
Ashburn 741
Toronto 679
Rome 502
Council Bluffs 499
Singapore 345
Beijing 335
Wilmington 331
Houston 306
Santa Clara 303
Phoenix 273
Princeton 235
Lawrence 223
Chandler 168
Ho Chi Minh City 115
Fairfield 95
Seattle 88
Woodbridge 83
Los Angeles 82
Shanghai 79
Hong Kong 71
Hanoi 56
Guangzhou 53
Cambridge 42
New York 40
Brooklyn 36
São Paulo 32
The Dalles 30
Shenzhen 27
Frankfurt am Main 24
Chicago 23
Redwood City 23
Helsinki 22
Columbus 21
Mexico City 20
Montreal 20
Islamabad 19
Milan 18
Atlanta 17
Dublin 17
Saint Petersburg 17
London 16
Netanya 15
Tokyo 15
Buffalo 14
Da Nang 14
Johannesburg 14
Warsaw 14
Orem 13
Redmond 12
Rio de Janeiro 12
Wuhan 12
San José 11
Xi'an 11
Jiaxing 10
Nanjing 10
Queens 10
Roubaix 10
San Francisco 10
Stockholm 10
Amsterdam 9
Bandung 9
Boston 9
Brasília 9
Haiphong 9
Kyiv 9
Wuxi 9
Ankara 8
Charlotte 8
Chennai 8
Manchester 8
Wroclaw 8
Curitiba 7
Denver 7
Detroit 7
Hyderabad 7
Las Vegas 7
Munich 7
Nairobi 7
Turku 7
Abbeville 6
Baghdad 6
Biên Hòa 6
Boardman 6
Bologna 6
Changsha 6
Hải Dương 6
Jakarta 6
Philadelphia 6
Quanzhou 6
Seoul 6
Tashkent 6
Washington 6
Zhengzhou 6
Belo Horizonte 5
Caracas 5
Guatemala City 5
Totale 11.089
Nome #
Angiogenesis and Hypertension: The Dual Role of Anti-Hypertensive and Anti-Angiogenic Therapies 149
Ketogenic Diet and Other Dietary Intervention Strategies in the Treatment of Cancer 140
RISK: A Random Optimization Interactive System Based on Kernel Learning for Predicting Breast Cancer Disease Progression 134
A re-evaluation of carcinoembryonic antigen (CEA) as a serum marker for breast cancer: A prospective longitudinal study 133
A reliable and reproducible technique for DNA Fingerprinting in Biorepositories: A Pilot Study from BioBIM 119
A Comprehensive Procedural Approach to Genotyping KRAS and BRAF from Paraffin Embedded Tissues for Diagnostic Purposes 118
Look beyond Catechol-O-Methyltransferase genotype for cathecolamines derangement in migraine: the BioBIM rs4818 and rs4680 polymorphisms study 112
Activation of blood coagulation in breast cancer - relationship to clinical outcome 111
Aging: an important risk factor in chemotherapy-associated vascular diseases 110
Soluble CD40 ligand (sCD40L) plasma levels in non-small cell lung cancer 106
HEMOSTATIC BALANCE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY-DISEASE 103
[New insights in the pathogenesis of prothrombotic state associated with hypercholesterolemia] 103
An importance of identification of double variant methylenetetrahydrofolate reductase gene C677T and A1298C in cis configuration for pharmacogenetic studies 101
Association between migraine and ACE gene (insertion/deletion) polymorphism: the BioBIM study 100
A global assay sensitive to activated protein C abnormalities is predictive for chemotherapy-associated venous thromboembolism 98
TAG-72 expression and its role in the biological evaluation of human colorectal cancer 94
Postsurgical chemotherapy in stage IB nonsmall cell lung cancer: Long-term survival in a randomized study 93
An activated protein C-dependent thrombin generation assay predicts chemotherapy-associated venous thromboembolism in cancer patients 93
Anoxia-Reoxygenation Enhances Platelet Thromboxane A2 Production via Reactive Oxygen Species-Generated NOX2 Effect in Patients Undergoing Elective Percutaneous Coronary Intervention 91
Neutrophil/lymphocyte ratio helps select metastatic pancreatic cancer patients benefitting from oxaliplatin 91
Acid citrate dextrose (ACD) formula A as a new anticoagulant in the measurement of in vitro platelet aggregation 90
Absolute neutrophil counts and fibrinogen levels as an aid in the early diagnosis of acute myocardial infarction 90
A multiparametric index of platelet in vitro aggregation in cerebrovascular disease 89
NEGATIVE PROGNOSTIC VALUE OF PLASMA PAI-1 (PLASMINOGEN ACTIVATOR INHIBITOR-1) LEVELS IN BREAST CANCER PATIENTS 88
Endothelial dysfunction and oxidative stress in arterial hypertension 87
Platelet activation in type 2 diabetes mellitus 85
Arterial hypertension and cardiovascular risk: need for a combined strategy of intervention 84
Impaired Functionality of the Protein C Anticoagulant Pathway is Associated with Increased Tumor Necrosis Factor-Alpha Levels in Patients with Metastatic Colorectal Cancer 84
Abnormal ventricular late potentials and in vivo platelet activation in Myotonic Dystrophy 83
Thromboembolic Events in Patients Treated with Anti-Angiogenic Drugs 83
CORRELATION BETWEEN POSITIVE CA-72-4 SERUM LEVELS AND LYMPH-NODE INVOLVEMENT IN PATIENTS WITH GASTRIC-CARCINOMA 82
Chronic obstructive pulmonary disease. A possible correlation between platelet aggregation tests and respiratory indexes. ECOB Group 82
“Personal and sensitive data in the e-health-IoT universe” 82
Platelet activation, inflammatory mediators and hypercholesterolemia 80
Role of interleukin-6 in the diagnosis of acute aortic dissection 80
Assay for the detection of anti-idiotypic antibodies to monoclonal antibody B72.3 80
Soluble P-selectin: A marker of platelet hyperactivity in patients with chronic obstructive pulmonary disease 78
EFFECTS ON PLATELET-FUNCTION BY HUMAN INTERFERON-BETA IN CARCINOMA PATIENTS 78
Contribution of platelet-derived CD40 ligand to inflammation, thrombosis and neoangiogenesis 78
Ganglioside content of human platelets - Differences in resting and activated platelets 78
Machine learning approach to predict medication overuse in migraine patients 78
Decreased plasma levels of soluble receptor for advanced glycation end products in type 2 diabetes mellitus: association with oxidative stress and metabolic control 77
Impact of chemotherapy on activated protein C-dependent thrombin generation - association with venous thromboembolism occurrence 77
PD-L1 Is Highly Expressed in Malignant Mesothelioma and PD-1(+)Lymphocytes within Malignant Effusions Induce PD-L1 Expression 76
EVALUATION OF THE CLINICAL UTILITY OF PLATELET-AGGREGATION STUDIES IN THE LONG-TERM FOLLOW-UP OF PATIENTS WITH ATHEROSCLEROTIC VASCULAR-DISEASE 76
Effects of storage on in vitro platelet responses: Comparison of ACD and Na citrate anticoagulated samples 76
Enhanced interleukin-1 beta in hypercholesterolemia - Effects of simvastatin and low-dose aspirin 76
Radioimmunoscintigraphy of colon cancer with iodine-131-labeled B72.3 monoclonal antibody 76
ROLE OF TUMOR-CELL MEMBRANE GANGLIOSIDES IN PROMOTING PLATELET PROAGGREGATING ACTIVITY 76
Higher oxidative stress in hepatitis C than hepatitis B virus cirrhotic patients 75
Interleukin-6 and haemostatic system in patients with chronic obstructive pulmonary disease 75
TNFA Gene Promoter Polymorphisms and Susceptibility to Recurrent Pregnancy Loss in Italian Women 74
Evaluation of the CA 242 tumor antigen as a potential serum marker for colorectal cancer 74
Dopaminergic symptoms in migraine: A cross-sectional study on 1148 consecutive headache center-based patients 74
Trombofilia ereditaria e poliabortività: studio osservazionale in 150 pazienti 73
Risk Assessment for Venous Thromboembolism in Chemotherapy-Treated Ambulatory Cancer Patients 73
CLINICAL-EVALUATION OF THE NEW TUMOR-MARKER TAG-72 73
Association of low-grade inflammation and platelet activation in patients with hypertension with microalbuminuria 73
Hypercoagulability state in patients with chronic obstructive pulmonary disease. Chronic Obstructive Bronchitis and Haemostasis Group 73
Clinical utility of CA 72-4 serum marker in the staging and immediate post-surgical management of gastric cancer patients 73
Platinum-based compounds and risk for cardiovascular toxicity in the elderly: role of the antioxidants in chemoprevention 73
Artificial intelligence for cancer-associated thrombosis risk assessment 73
Towards the Interpretability of Machine Learning Predictions for Medical Applications Targeting Personalised Therapies: A Cancer Case Survey 73
Relation of Cytokine Production and Helicobacter Pylori Infection to Coronary Heart Disease 72
Establishment of a biorepository for migraine research: the experience of Interinstitutional Multidisciplinary BioBank (BioBIM) 72
Random optimization interactive system based on Kernel learning (RISK) for venous thromboembolism risk assessment in chemotherapy-treated cancer patients 72
High-sensitive D-dimer Determination for the Prediction of Chemotherapy-associated Venous Thromboembolism in Lung Cancer Patients 72
Soluble E-selectin levels and CEA expressing blood-borne cells in colorectal cancer patients. A causal relationship? 72
The role of anti-CGRP antibodies in the pathophysiology of primary headaches 72
Ideal Body Mass Index (BMI) difference between curatively resected and metastatic colorectal cancer (CRC) patients on chemotherapy 72
Onabotulinum toxin A in the treatment of chronic migraine: patient selection and special considerations 72
Irinotecan or Oxaliplatin: Which is the First Move for the Mate? 72
Predicting VTE in Cancer Patients: Candidate Biomarkers and Risk Assessment Models 72
Determinants of thromboxane biosynthesis in patients with moderate to severe chronic kidney disease 71
Association between Migraine and Progesterone Receptor Gene PROGINS Polymorphism: the BioBIM study 71
Validation of a machine learning approach for venous thromboembolism risk prediction in oncology 71
Association of LTA and SOD Gene Polymorphisms with Cerebral White Matter Hyperintensities in Migraine Patients 70
Novel High-sensitive D-dimer determination predicts chemotherapy-associated venous thromboembolism in cancer patients 70
Determinants of platelet activation in pulmonary arterial hypertension 70
IS THE CD54 PROTEIN (ICAM-1) INVOLVED IN PLATELET-TUMOR CELL-INTERACTION 70
Vascular endothelial growth factor (VEGF-A) plasma levels in non-small cell lung cancer: relationship with coagulation and platelet activation markers 70
Breast Cancer Prognosis Using a Machine Learning Approach 70
Circulating Biomarkers in Migraine: New Opportunities for Precision Medicine 70
In vitro interactions between blood platelets and human colorectal tumor cells 69
Is CEA serum measurement useful in monitoring breast cancer patients? 69
Serum Metalloproteinase-9 Levels in Patients with Coronary Heart Disease A Novel Marker of Inflammation 69
CA 72-4 radioimmunoassay for the detection of the TAG-72 carcinoma-associated antigen in serum of patients 69
Low-density lipoprotein-lowering medication and platelet function 69
Ideal Body Mass Index (BMI) is significantly different between curatively resected and metastatic colorectal cancer (CRC) patients on chemotherapy 69
Combined evaluation of CA 242 and CEA tumor markers in the management of colorectal cancer 69
Vascular endothelial growth factor levels in melanoma Relationship with coagulation and platelet activation markers 68
NADPH OXIDASE-RELATED OXIDATIVE STRESS ENHANCES PLATELET THROMBOXANE PRODUCTION IN ASPIRIN-TREATED PATIENTS UNDERGOING ELECTIVE PERCUTANEOUS CORONARY INTERVENTION 68
Potential artifact for the increase of tumor associated antigens in serum samples from patients injected with monoclonal antibodies 68
Non-Communicable Diseases: Gender Differences in Therapy 67
Association between increased tumor necrosis factor alpha levels and acquired activated protein C resistance in patients with metastatic colorectal cancer 67
Prognostic value of vascular endothelial growth factor tumor tissue content of colorectal cancer 67
Prognostic Significance of Serum Adipokine Levels in Colorectal Cancer Patients 67
Inflammation, insulin resistance, and obesity 67
Effects of normothermic versus hypothermic cardiopulmonary bypass on cytokine production and platelet function 66
Circulating Levels of Pro-Inflammatory Cytokines in Isolated Limb Perfusion 66
Totale 8.154
Categoria #
all - tutte 139.937
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 139.937


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022874 0 0 0 4 3 3 284 238 27 279 4 32
2022/2023841 490 18 18 54 33 11 2 35 31 65 84 0
2023/2024497 4 0 9 121 26 20 7 25 1 49 1 234
2024/20252.053 88 477 110 90 110 355 147 106 206 14 70 280
2025/20265.110 396 525 695 369 373 597 667 301 459 571 72 85
2026/20271.980 61 617 798 504 0 0 0 0 0 0 0 0
Totale 15.930